Metastatic head and neck cancer
Clinical trials for Metastatic head and neck cancer explained in plain language.
Never miss a new study
Get alerted when new Metastatic head and neck cancer trials appear
Sign up with your email to follow new studies for Metastatic head and neck cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine plus immunotherapy shows promise against HPV-Linked head and neck cancer
Disease control OngoingThis trial tests whether adding a vaccine called BNT113 to the immunotherapy drug pembrolizumab works better than pembrolizumab alone for people with advanced head and neck cancer linked to HPV16. About 350 participants will receive either the combination or the standard single d…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase 2/3 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo aims to boost immunotherapy for head and neck cancer
Disease control OngoingThis phase 2 trial tests whether adding ramucirumab to pembrolizumab (Keytruda) works better than pembrolizumab alone for people with PD-L1 positive head and neck cancer that has come back or spread. About 37 participants will receive either the combination or the single drug. Th…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Blood tests could reveal who benefits from immunotherapy
Knowledge-focused OngoingThis study looks at how well immunotherapy works in people with advanced lung or head and neck cancers. Researchers will take blood samples before and after treatment to measure how the body clears the drug and how tumor cells in the blood change. The goal is to find markers that…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:10 UTC